Loading...

URGN UROGEN PHARMA LTD Company Mergers 8-K Filing

RGN

RGN

UROGEN PHARMA LTD

(URGN)

2025 8-K

Show Summary

Show Summary

New Product Launches

Financial Statements

Financial Results

Asset Acquisition

Investor Presentation

Financial Results

Director Resignation

Financial Results

Annual Meeting Approval

Public Offering

Positive Data from Phase 3 ...

Financial Results Announcement

Financial Results Announcement

Presentation at Conference

Notice of ANDA Submission

Agreement and Phase 3 Study

Amendment to Manufacturing ...

Financial Results Announcement

Annual Meeting of Shareholders

Financial Results Announcement

Private Placement

Financial Results Announcement

External Links:

On February 14, 2025, Urogen Pharma Ltd entered into an Asset Purchase Agreement to acquire assets from IconOVir Bio, Inc. for $4 million in shares and potential future payments totaling $15 million plus royalties based on sales of the acquired produ

AI Assistant

UROGEN PHARMA LTD

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.